Mark Tomlinson, Senior Director of Technology Operations at encapsia, explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.
Read more on Outsourcing Pharma
To properly support and enable DCTs, we must undergo a digital transformation; we must eliminate the pain involved in aggregating and integrating data from multiple sources, reduce the lag between data capture and data analysis, and improve the ability of study teams to gain deeper insights and operationalize the data.
Read more on Contract Pharma
Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.
Read more on PharmaVoice
This article is taken from International Clinical Trials May 2021, pages 50-52. © Samedan Ltd.